+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Acute Coronary Syndrome Drug"

From
From
Acute Coronary Syndrome - Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome - Global Strategic Business Report

  • Report
  • April 2025
  • 182 Pages
  • Global
From
From
Acute coronary syndrome: Competitive Landscape - Product Thumbnail Image

Acute coronary syndrome: Competitive Landscape

  • Report
  • August 2024
  • 79 Pages
  • Global
From
Anti-Platelet Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Platelet Agents - Global Strategic Business Report

  • Report
  • April 2025
  • 94 Pages
  • Global
From
Acute Coronary Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Acute Coronary Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Acute Coronary Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Coronary Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Cardiac Troponin Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Cardiac Troponin Market Analysis & Forecast to 2024-2034

  • Report
  • March 2024
  • 200 Pages
  • Global
From
From
From
  • 17 Results (Page 1 of 1)
Loading Indicator

Acute Coronary Syndrome (ACS) is a term used to describe a range of conditions caused by a sudden decrease in blood flow to the heart. This can lead to chest pain, heart attack, and other cardiovascular complications. ACS is a major cause of death and disability worldwide. The ACS drug market is a subset of the larger cardiovascular drug market. It includes drugs used to treat ACS, such as antiplatelet agents, anticoagulants, and statins. These drugs are used to reduce the risk of further complications and improve patient outcomes. Additionally, drugs used to treat the symptoms of ACS, such as pain medications, are also included in this market. The ACS drug market is highly competitive, with many large pharmaceutical companies offering a range of products. Some of the major players in this market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and Novartis. Show Less Read more